Delivery Order SPE2DB22D1103-SPE2DB25FTSN9
- Not listed
- The Defense Logistics Agency awarded a $7,804.29 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This contract represents a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. As a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). The contract, valued at $2,601.43, is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $2,601.43 delivery order to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a pediatric pharmaceutical supply requirement fulfilled through competitive procurement with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $7,190.02 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 ml pen injections on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical treatment commonly prescribed for osteoporosis management,...
- AmerisourceBergen Drug Corp was awarded a $54,516.23 delivery order contract by the Defense Logistics Agency on July 22, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injections). The contract is set to be completed by July 23, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's...
- This delivery order, valued at $5,202.86, represents a competitive award to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) to support federal healthcare needs. Issued by the Defense Logistics Agency on July 22, 2025, with completion expected by July 23, 2025, the contract utilizes firm fixed pricing and carries no set-aside designation. The pharmaceutical product will be delivered from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,601.43 for Forteo (560 mcg/2.24 mL pen injection), a pharmaceutical product used in osteoporosis treatment. This firm fixed-price delivery order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was competitively procured with no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,758.08 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections. This firm fixed price delivery order was awarded competitively on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical product used in the treatment of osteoporosis and bone-related...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Forteo 560 mcg/2.24 ml pen injections. The contract has a ceiling value of $12,869.67 and is a firm fixed-price, non-set-aside award with a performance period through May 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,289.89, is for the delivery of Forteo 560 mcg/2.24 ml pen injections. The contract is a firm fixed-price delivery order with an ultimate completion date of April 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTSN9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,392.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 ml pen injections) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The contractor's track record demonstrates capability to efficiently deliver diverse pharmaceutical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 7/23/25 |